title: Mapping the conformational space accessible to catechol-O-methyltransferase.
abstract: Methylation catalysed by catechol-O-methyltransferase (COMT) is the main pathway of catechol neurotransmitter deactivation in the prefrontal cortex. Low levels of this class of neurotransmitters are held to be causative of diseases such as schizophrenia, depression and Parkinson's disease. Inhibition of COMT may increase neurotransmitter levels, thus offering a route for treatment. Structure-based drug design hitherto seems to be based on the closed enzyme conformation. Here, a set of apo, semi-holo, holo and Michaelis form crystal structures are described that define the conformational space available to COMT and that include likely intermediates along the catalytic pathway. Domain swaps and sizeable loop movements around the active site testify to the flexibility of this enzyme, rendering COMT a difficult drug target. The low affinity of the co-substrate S-adenosylmethionine and the large conformational changes involved during catalysis highlight significant energetic investment to achieve the closed conformation. Since each conformation of COMT is a bona fide target for inhibitors, other states than the closed conformation may be promising to address. Crystallographic data for an alternative avenue of COMT inhibition, i.e. locking of the apo state by an inhibitor, are presented. The set of COMT structures may prove to be useful for the development of novel classes of inhibitors.
authors.affiliation: Molecular Design and Chemical Biology, F. Hoffmann-La Roche, Grenzacher Strasse 124, Basel, Switzerland.
authors.forename: Andreas
authors.initials: A
authors.lastname: Ehler
authors.affiliation: Molecular Design and Chemical Biology, F. Hoffmann-La Roche, Grenzacher Strasse 124, Basel, Switzerland.
authors.forename: Jörg
authors.initials: J
authors.lastname: Benz
authors.affiliation: Molecular Design and Chemical Biology, F. Hoffmann-La Roche, Grenzacher Strasse 124, Basel, Switzerland.
authors.forename: Daniel
authors.initials: D
authors.lastname: Schlatter
authors.affiliation: Molecular Design and Chemical Biology, F. Hoffmann-La Roche, Grenzacher Strasse 124, Basel, Switzerland.
authors.forename: Markus G
authors.initials: MG
authors.lastname: Rudolph
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D020134:Catalytic Domain; D002394:Catechol O-Methyltransferase / Q000737:chemistry*; D018360:Crystallography, X-Ray; D006801:Humans; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D011487:Protein Conformation; D051381:Rats; D017386:Sequence Homology, Amino Acid
chemical_list: D002394:Catechol O-Methyltransferase
keywords: S-adenosylmethionine; SAM; catechol-O-methyltransferase; catecholamine metabolism; neurotransmitter degradation
references.citation: Angew Chem Int Ed Engl. 2009;48(48):9092-6
references.pmid: 19882607
references.citation: Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
references.pmid: 16369096
references.citation: Structure. 2004 Jun;12(6):1099-108
references.pmid: 15274929
references.citation: Chembiochem. 2004 Sep 6;5(9):1270-4
references.pmid: 15368579
references.citation: Nat Struct Biol. 2001 Mar;8(3):211-4
references.pmid: 11224563
references.citation: Biopolymers. 2009 Dec;91(12):1029-37
references.pmid: 19280639
references.citation: J Mol Biol. 2008 Jun 27;380(1):120-30
references.pmid: 18486144
references.citation: Angew Chem Int Ed Engl. 2001 Nov 5;40(21):4040-4042
references.pmid: 12404486
references.citation: Science. 2012 May 25;336(6084):1030-3
references.pmid: 22628654
references.citation: Pharmacol Rev. 1999 Dec;51(4):593-628
references.pmid: 10581325
references.citation: Structure. 2003 Oct;11(10):1219-26
references.pmid: 14527390
references.citation: Chemistry. 2011 May 27;17(23):6369-81
references.pmid: 21538606
references.citation: Nature. 2005 Sep 8;437(7056):266-9
references.pmid: 16148936
references.citation: Biochem Pharmacol. 1989 Nov 15;38(22):3953-6
references.pmid: 2597177
references.citation: Acta Crystallogr D Biol Crystallogr. 2012 Mar;68(Pt 3):253-60
references.pmid: 22349227
references.citation: Pharmacol Rev. 1975 Jun;27(2):135-206
references.pmid: 1103160
references.citation: Biochem Pharmacol. 1972 Apr 15;21(8):1200-3
references.pmid: 5064256
references.citation: Biochim Biophys Acta. 1997 Mar 15;1334(2-3):200-6
references.pmid: 9101714
references.citation: Pharmacol Ther. 2007 Mar;113(3):537-45
references.pmid: 17270273
references.citation: Methods Mol Biol. 2008;426:419-35
references.pmid: 18542881
references.citation: Int J Biochem. 1983;15(5):733-8
references.pmid: 6862087
references.citation: Prog Drug Res. 1992;39:291-350
references.pmid: 1475365
references.citation: Curr Mol Med. 2011 Dec;11(9):732-43
references.pmid: 21999147
references.citation: Nat Struct Biol. 2002 Nov;9(11):877-85
references.pmid: 12379842
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
references.pmid: 20383002
references.citation: Nat Struct Biol. 1997 Apr;4(4):269-75
references.pmid: 9095194
references.citation: J Biol Chem. 1958 Sep;233(3):702-5
references.pmid: 13575440
references.citation: Org Biomol Chem. 2003 Jan 7;1(1):42-9
references.pmid: 12929389
references.citation: Biochemistry. 1995 Apr 4;34(13):4202-10
references.pmid: 7703232
references.citation: Adv Exp Med Biol. 2012;747:137-52
references.pmid: 22949116
references.citation: J Struct Biol. 2009 Mar;165(3):133-9
references.pmid: 19111934
references.citation: Drug Metab Dispos. 2002 Feb;30(2):199-207
references.pmid: 11792691
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
references.pmid: 20124692
references.citation: Trends Biotechnol. 2001 Dec;19(12):491-6
references.pmid: 11711191
references.citation: J Struct Funct Genomics. 2007 Dec;8(4):141-4
references.pmid: 17952628
references.citation: Mol Pharmacol. 2006 Jul;70(1):143-53
references.pmid: 16618795
references.citation: ChemMedChem. 2006 Mar;1(3):340-57
references.pmid: 16892369
references.citation: J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
references.pmid: 19461840
references.citation: Bioorg Med Chem Lett. 2013 Jul 15;23(14):4239-43
references.pmid: 23735744
references.citation: Protein Sci. 2002 Feb;11(2):371-80
references.pmid: 11790847
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3437-42
references.pmid: 9520384
references.citation: Chemistry. 2000 Mar 17;6(6):971-82
references.pmid: 10785817
references.citation: Nature. 1994 Mar 24;368(6469):354-8
references.pmid: 8127373
references.citation: Mol Pharmacol. 2002 Oct;62(4):795-805
references.pmid: 12237326